Педиатрическая фармакология (Mar 2014)

EXPERIENCE OF INTRAMUSCULAR METHOTREXATE USE IN A PATIENT WITH EARLY POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

  • E. I. Alexeeva,
  • T. V. Sleptsova,
  • T. M. Bzarova,
  • S. I. Valieva,
  • R. V. Denisova,
  • K. B. Isaeva,
  • E. V. Mitenko,
  • E. G. Chistyakova,
  • A. M. Chomakhidze,
  • A. N. Fetisova,
  • O. L. Lomakina,
  • N. I. Taybulatov

DOI
https://doi.org/10.15690/pf.v11i2.957
Journal volume & issue
Vol. 11, no. 2
pp. 48 – 54

Abstract

Read online

This article presents a case of severe course of polyarticular juvenile idiopathic arthritis. Active articular syndrome, high laboratory parameters of disease activity, severe incompetence were observed in a child by the therapy initiation. Successful use of intramuscular methotrexate in the dose of 15 mg/m2 of body surface per week is described. Exudative articular alterations, arthralgiae, morning stiffness duration reduced as early as one month after the therapy initiation in a child. Acute inflammatory articular alterations cut off, range of motions recovered completely in 4 out of the 6 affected joints, laboratory parameters of disease activity reduced and normalized (ESR and CRP), inactive disease stage was registered after 6 months of treatment. We did not observe any undesirable phenomena in the setting of methotrexate therapy.

Keywords